Beta-endorphin-induced decrease in hypothalamic dopamine turnover.
The effect of beta-endorphin on hypothalamic dopamine metabolism was examined in male rats. Intracisternal administration of synthetic human beta-endorphin (15 microgram blunted the alpha-methyltyrosine-induced decline in the concentration of hypothalamic dopamine. Also, beta-endorphin blunted the pargyline-induced accumulation of hypothalamic dopamine. beta-Endorphin either increased or failed to alter the basal concentration of hypothalamic dopamine and failed to alter the basal hypothalamic concentration of the dopamine metabolite, homovanillic acid. These data suggest that beta-endorphin decreases the turnover rate of hypothalamic dopamine and are consistent with the thesis that beta-endorphin decreases the release of dopamine from tuberoinfundibular dopamine neurons.
D000818:Animals; D004298:Dopamine / Q000378:metabolism*; D004723:Endorphins / Q000494:pharmacology*; D004837:Epinephrine / Q000378:metabolism; D006719:Homovanillic Acid / Q000378:metabolism; D007031:Hypothalamus / Q000187:drug effects / Q000378:metabolism*; D008297:Male; D008781:Methyltyrosines / Q000494:pharmacology; D009638:Norepinephrine / Q000378:metabolism; D010293:Pargyline / Q000494:pharmacology; D051381:Rats
D004723:Endorphins; D008781:Methyltyrosines; D010293:Pargyline; D004298:Dopamine; D009638:Norepinephrine; D006719:Homovanillic Acid; D004837:Epinephrine